Stay updated on Flotetuzumab EAP in AML: Investigational Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.

Latest updates to the Flotetuzumab EAP in AML: Investigational Clinical Trial page
- Check3 days agoChange DetectedA new revision entry v3.6.0 was added to the study's record history, and the previous revision v3.5.5 was removed, reflecting an update to the page's versioning.SummaryDifference0.3%

- Check11 days agoChange DetectedA new revision entry v3.5.5 was added to the page's history, and the previous revision v3.5.4 was removed from the list. This updates the version history to reflect the latest revision.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRecord History now shows a new revision entry, v3.5.4, indicating an update to the study record's revision history. The previous entry, v3.5.3, is removed from the current history view.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page footer’s system revision/version indicator was updated from v3.5.0 to v3.5.3, reflecting a platform update with no change to the study’s record contents.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the record history.SummaryDifference0.1%

- Check104 days agoChange DetectedAdded Revision v3.4.3 to the study record history. Removed Revision v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Flotetuzumab EAP in AML: Investigational Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.